Dihydroboldenone Cypionate, 100mg (1 vial)

Mechanism of medicine action:

Dihydroboldeonone Cypionate binds to the androgen receptor, leading to the activation of gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics. It is converted to dihydrotestosterone (DHT) in the body, which is a more potent form of testosterone that is responsible for many of its anabolic and androgenic effects.

Indications:

Dihydroboldeonone Cypionate is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone, such as
primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).

Contraindications:

Dihydroboldeonone Cypionate is contraindicated in individuals with known hypersensitivity to the drug, males with carcinoma of the breast, males with known or suspected carcinoma of the prostate gland, women who are pregnant, and patients with serious cardiac, hepatic or renal disease.

Precautions:

Patients with benign prostatic hypertrophy may develop acute urethral obstruction. Priapism or excessive sexual stimulation may develop. Oligospermia may occur after prolonged administration or excessive dosage. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every 6 months. In children, androgen treatment may
accelerate bone maturation without producing compensatory gain in linear growth.

Drug interactions:

Dihydroboldenone Cypionate may interact with anticoagulants, oral hypoglycemic agents, and corticosteroids, potentially altering their effects. Combinations with other anabolic steroids may also increase side effects, necessitating careful consideration and monitoring by healthcare providers.

Dosage:

The suggested dosage of Dihydroboldenone Cypionate is 200-400mg per week for men, administered via intramuscular injection. Women are advised to avoid using this steroid due to the risk of virilization.

Injection Site Care & Technique:

To ensure safe and comfortable administration of injectable products:

• Warm the vial to body temperature before use
• Use a sterile 25G–27G needle and syringe
• Inject slowly into the muscle to minimize tissue irritation
• Massage the area gently after injection
• Rotate injection sites regularly
• Avoid injecting into inflamed or previously used areas
• Store product upright and avoid excessive agitation

Storage:

Store in a dark, dry place, at room temperature. Do not refrigerate. Keep out of reach of children.

Regulatory Compliance Statements:

• This product complies with relevant regulatory guidelines.
• Certified under Good Manufacturing Practices (GMP).

Safety Information:

• Overdose Instructions: In case of overdose, seek immediate medical attention.
• Adverse Reactions: Report any adverse reactions to your healthcare provider.

Prescription-only medication. Administer under licensed medical supervision.